Medical Oncologist, FDA Clinical Reviewer

Oncology

Dr. Paul G. Kluetz, MD

Paul Kluetz is an expert in the field of Oncology. He went to University of Pittsburgh School of Medicine. Paul G. Kluetz, MD is a published doctor and has 18 publications published. The lastest was: 'Looking to the future in an unprecedented time for cancer drug development.' He is registered with Medicare and accepts Medicare payments.

Publications

Looking to the future in an unprecedented time for Cancer drug development.
FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer.
U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Pl...
Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate Cancer: U.S. Food and Drug Administrati...
Under-representation of racial minorities in prostate Cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
Radium ra 223 dichloride injection: u.s. Food and drug administration drug approval summary.
Clinical Trial Design for the Development of New Therapies for Nonmuscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Ass...
Pain palliation measurement in Cancer clinical trials: The US Food and Drug Administration perspective.
Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors.
Acute pulmonary embolism: imaging in the emergency department.
Combined PET/CT Imaging in Oncology. Impact on Patient Management.
20. The Case for PET/CT. Experience at the University of Pittsburgh.
Successes and Challenges of PARP Inhibitors in Cancer Therapy.
Back pain emergencies.
A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate Cancer.
Angiogenesis inhibitors in the treatment of prostate Cancer.
Successful treatment of small cell lung Cancer during pregnancy.

Schools

University of Pittsburgh Main Campus

Conditions Treated

Anemia
Pancreatic Cancer

Doctors Specialties

Medical Oncology
Oncology

Accepted Insurances

Education

National Institutes of Health Clinical Center
University of Maryland
University of Pittsburgh School of Medicine

Hospital

MedStar Georgetown University Hospital

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1205951316
Last Name Of The Provider	KLUETZ
First Name Of The Provider	PAUL
View All

Similar Doctors

	Carolyn K. Francis
	Carrie Tilley, ANP
	Dr. Michaele C. Christian, MD
	Dr. Louis M. Weiner, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Paula R. Pohlmann, MD This Doctor is OpenDoctor Recommended.
	Dr. Julia A. Beaver, MD This Doctor is OpenDoctor Recommended.
	Dr. Brandon G. Smaglo, MD This Doctor is OpenDoctor Recommended.
	Dr. Deepa S. Subramaniam, MD This Doctor is OpenDoctor Recommended.
	Dr. Saulius Naujokaitis, MD This Doctor is OpenDoctor Recommended.
	Dr. Catherine M. Broome, MD This Doctor is OpenDoctor Recommended.
	Dr. Sandra J. Ginsberg, MD This Doctor is OpenDoctor Recommended.